As more innovative – yet even more expensive – therapies enter the U.S. market, brand marketers will have to find equally new and innovative ways to prove the value of their medicines to payers and patients, especially as insurance plans continue to put more of the cost burden on patients.
2015 U.S. trends in aggregate spend, disclosure, and transparency
Biotech, Centers for Medicare & Medicaid Services, Centers for Medicare and Medicaid Services (CMS), CMS, Europe, European Federation of Pharmaceutical Industries and Associations (EFPIA), February 2016, Healthcare Physicians, Issue Archives, Medical Devices, Physicians, Surveys, Trends, U.S. Sunshine LawWhat are key trends in the transparency compliance landscape? And, how are life sciences manufacturers tackling growing requirements